MedPath

Acid-base Balance in Patients Undergoing Colonoscopy

Phase 1
Conditions
Colonoscopy
Bowel Preparation
Interventions
Drug: Normal saline solution
Drug: Lactated Ringer's solution
Registration Number
NCT01250886
Lead Sponsor
Mahidol University
Brief Summary

The purpose of this study is to determine whether fluid administration in patients undergoing colonoscopy should affect acid-base disorder in term of the strong ion differences.

Detailed Description

This is a prospective, double-blinded, randomized control trial. The study enrolls 90 consecutive outpatients, well-prepared bowel, scheduled to undergo routine colonoscopy for screening, surveillance, or diagnosis of colorectal diseases. At the outpatient clinic, the co-researcher invites patients who meet the inclusion criteria to join the study. The process of the project is explained to the interested patients in details before an informed consent is obtained and the first blood sample is conducted.

On the day of colonoscopy, all participants are randomized equally into three groups: Normal saline solution (NSS, n = 30) as control group, lactated Ringer's solution (LRS, n = 30) and acetated Ringer's solution (ARS, n = 30) as treatment groups. The second blood sample is obtained from patients via 20-gauge needle in either forearm immediately before an allocated intravenous (IV) fluid administered on the same site. The volume of fluid is calculated by means of Holliday and Segar formula.

The colonoscopy under total intravenous anesthesia is performed between 9:00 a.m. and 3:00 p.m. At the end of colonoscopy, the patients spontaneously wake up in the recovery room. After they gain conscious and all vital signs are stable; the intravenous fluid is off and the third blood sample is taken in the other forearm. After completion of the procedure, the patient is advised to follow the discharge instructions.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
90
Inclusion Criteria
  • male or non-pregnant
  • non-lactating female out-patient scheduled for routine colonoscopy
  • over 18 years of age
  • eligible for taking PEG or NaP for bowel preparation, and willing to sign informed consent.
Exclusion Criteria
  • insulin-dependant diabetes
  • renal insufficiency (creatinine >2.0 mg⁄ dL)
  • renal dialysis
  • uncontrolled congestive heart failure (American Heart Association Classification III or IV congestive heart failure)
  • unstable angina
  • untreated cardiac arrhythmia
  • ileus and⁄or acute obstruction or perforation
  • ileostomy
  • presence of a colostomy
  • history of a partial colon resection
  • active gastrointestinal bleeding.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Normal saline solutionNormal saline solutionBlood sample is obtained from patient in either forearm immediately before a Normal saline solution administered on the same site. The volume of fluid administration is calculated by means of Holliday and Segar formula.
Lactated Ringer's solutionLactated Ringer's solutionLactated Ringer's solution is administered. The volume of fluid administration is calculated by means of Holliday and Segar formula.
Acetate Ringer's solutionAcetate Ringer's solutionAcetate Ringer's solution is administered. The volume of fluid administration is calculated by means of Holliday and Segar formula.
Primary Outcome Measures
NameTimeMethod
Number of Patients with Acid-base disorder as a Measure of Strong Ion Difference.3 days

The strong ion difference (SID) is calculated by means of the differences between the positively and negatively charged strong ions in plasma. The strong ion difference affected by bowel preparation and intravenous fluid administration during colonoscopy.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath